Join Today and Give Back

New Drug Candidate Uses Novel Absorption Method to Target Cancer Cells in Mice

August 17, 2022


Read time:

5-15 mins
Multfunctional Kinase Inhibitor Illustration Press Release 5B39 5D Edited
Presented by Health Lab

A team of U-M researchers is developing a new anti-cancer drug, absorbed through the lymphatic system in the gut rather than the bloodstream. Brian D. Ross, Ph.D., the Roger A. Berg Research Professor of Radiology at the U-M Medical School, discusses previous challenges with drug circulation and treatment while providing an overview of the new drug. The faculty expert also discusses future applications and research opportunities.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.